Evidence map›Paper›PMID 30616390›Full record

ArticleIntegrative cancer therapies

Effects of Vitamin D Use on Health-Related Quality of Life of Breast Cancer Patients in Early Survivorship.

M Robyn Andersen, Erin Sweet, Shelly Hager, Marcia Gaul, Fred Dowd, Leanna J Standish

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07598032 (Comparative Analysis of Immunological Responses to Vitamin D Replacement Therapy in Black and West African Men Diagnosed With Prostate Cancer), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07598032 phase3not yet recruitingnot on this map

Comparative Analysis of Immunological Responses to Vitamin D Replacement Therapy in Black and West African Men Diagnosed With Prostate Cancer: Elucidating Differential Effects on Immune Function Between Patients With Localized Disease and Those With Metastatic Progression

TypeinterventionalSponsorUniversity of Ilorin Teaching HospitalRan2026 to 2028Enrolled200ConditionsProstate Cancer (Adenocarcinoma), Vitamin D on Tumor Response and Inflammatory MarkersArmsvitamin D 25(OH)D
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Supplement use and its impact on daily life of cancer patients: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  5. Associations between Serum 25-Hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Patients with Breast Cancer: A Longitudinal Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

M Robyn Andersen1 Fred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID 0000-0002-6083-4619
Erin Sweet3 Bastyr University, Kenmore, WA, USA.
Shelly Hager1 Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Marcia Gaul1 Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Fred Dowd3 Bastyr University, Kenmore, WA, USA.
Leanna J Standish3 Bastyr University, Kenmore, WA, USA.
Bastyr University · USFred Hutch Cancer Center · USUniversity of Washington · US

Funding

Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes StudyR01AT005873 · NCCIH · BASTYR UNIVERSITY · PI ANDERSEN, MARIN R, STANDISH, LEANNA J · 2010 to 2014
$2.9M
NCCIH NIH HHS R01 AT005873
6 · The paper itself

Abstract

backgroundVitamin D supplements may prevent recurrence, prolong survival, and improve mood for women with breast cancer, although evidence for these effects is preliminary.

methodsThis report describes vitamin D supplement use by 553 breast cancer patient/survivors (193 who used a naturopathic oncology [NO] provider and 360 who did not) participating in a matched cohort study of breast cancer outcomes.

resultsWe found that more than half of breast cancer patients reported using vitamin D supplements. Women who received care from NO providers in early survivorship may be more likely to use vitamin D supplements ( P < .05). Approximately 30% of breast cancer patients with blood levels recorded in their medical chart were potentially vitamin D deficient (<30 ng/mL). Vitamin D supplement use at study enrollment was associated with higher levels of self-reported health-related quality of life (HRQOL) at enrollment ( P < .05) and predicted better HRQOL at 6-month follow-up ( P < .05). Sufficient blood levels of vitamin D recorded between enrollment and follow-up were also associated with better HRQOL at follow-up ( P < .05).

conclusionsVitamin D supplementation by breast cancer patients is common both during and after treatment for breast cancer, but deficiency may also be common. NO and conventional providers may be able to promote vitamin D sufficiency through vitamin D supplementation and by encouraging healthy solar exposure. Further studies should be undertaken examining whether vitamin D supplementation and higher blood levels might improve HRQOL among women with breast cancer in early survivorship.

Indexed as

Breast NeoplasmsCancer SurvivorsCohort StudiesDietary SupplementsFemaleHumansMiddle AgedNutrition TherapyQuality of LifeSurvivorshipVitamin DVitamin D DeficiencyVitamin Dbreast cancerCAMhealth-related quality of lifesurvivorshipvitamin D

Identifiers

PMID30616390
PMCPMC7240878
OpenAlexW2908889945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.